StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$122.86+1.94 (+1.60%)

Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –

Haemonetics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Haemonetics's revenue for the twelve months ending Jun 27, 2026 was $1.35B, up 0.4% year over year. For fiscal 2026 it was $1.33B, down 2.0% from the year before. Over ten years it grew 3.9% a year on average. The highest annual figure on record is $1.36B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 28, 2026$1.33B-2.0%
FY2025Mar 29, 2025$1.36B+4.0%
FY2024Mar 30, 2024$1.31B+12.0%
FY2023Apr 1, 2023$1.17B+17.7%
FY2022Apr 2, 2022$993.20M+14.1%
FY2021Apr 3, 2021$870.46M-11.9%
FY2020Mar 28, 2020$988.48M+2.2%
FY2019Mar 30, 2019$967.58M+7.0%
FY2018Mar 31, 2018$903.92M+2.0%
FY2017Apr 1, 2017$886.12M-2.5%
FY2016Apr 2, 2016$908.83M-0.2%
FY2015Mar 28, 2015$910.37M-3.0%
FY2014Mar 29, 2014$938.51M+5.2%
FY2013Mar 30, 2013$891.99M+22.6%
FY2012Mar 31, 2012$727.84M+7.6%
FY2011Apr 2, 2011$676.69M+4.8%
FY2010Apr 3, 2010$645.43M+8.0%
FY2009Mar 28, 2009$597.88M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$339.38M+5.6%
Q4 FY2026CQ1 2026Mar 28, 2026$346.35M+4.8%
Q3 FY2026CQ4 2025Dec 27, 2025$338.97M-2.7%
Q2 FY2026CQ3 2025Sep 27, 2025$327.32M-5.3%
Q1 FY2026CQ2 2025Jun 28, 2025$321.39M-4.4%
Q4 FY2025CQ1 2025Mar 29, 2025$330.60M-3.7%
Q3 FY2025CQ4 2024Dec 28, 2024$348.54M+3.7%
Q2 FY2025CQ3 2024Sep 28, 2024$345.51M+8.6%
Q1 FY2025CQ2 2024Jun 29, 2024$336.17M+8.0%
Q4 FY2024CQ1 2024Mar 30, 2024$343.29M+12.8%
Q3 FY2024CQ4 2023Dec 30, 2023$336.25M+10.1%
Q2 FY2024CQ3 2023Sep 30, 2023$318.18M+7.0%
Q1 FY2024CQ2 2023Jul 1, 2023$311.33M+19.1%
Q4 FY2023CQ1 2023Apr 1, 2023$304.42M+14.9%
Q3 FY2023CQ4 2022Dec 31, 2022$305.30M+17.5%
Q2 FY2023CQ3 2022Oct 1, 2022$297.49M+24.0%
Q1 FY2023CQ2 2022Jul 2, 2022$261.46M+14.4%
Q4 FY2022CQ1 2022Apr 2, 2022$265.00M+17.8%
Q3 FY2022CQ4 2021Jan 1, 2022$259.77M+8.1%
Q2 FY2022CQ3 2021Oct 2, 2021$239.90M+14.5%
Q1 FY2022CQ2 2021Jul 3, 2021$228.53M+16.8%
Q4 FY2021CQ1 2021Apr 3, 2021$225.03M-5.6%
Q3 FY2021CQ4 2020Dec 26, 2020$240.37M-7.2%
Q2 FY2021CQ3 2020Sep 26, 2020$209.49M-17.1%
Q1 FY2021CQ2 2020Jun 27, 2020$195.58M-18.0%
Q4 FY2020CQ1 2020Mar 28, 2020$238.49M-4.3%
Q3 FY2020CQ4 2019Dec 28, 2019$258.97M+4.7%
Q2 FY2020CQ3 2019Sep 28, 2019$252.57M+4.5%
Q1 FY2020CQ2 2019Jun 29, 2019$238.45M+4.0%
Q4 FY2019CQ1 2019Mar 30, 2019$249.30M+6.7%
Q3 FY2019CQ4 2018Dec 29, 2018$247.36M+5.7%
Q2 FY2019CQ3 2018Sep 29, 2018$241.58M+7.2%
Q1 FY2019CQ2 2018Jun 30, 2018$229.35M+8.7%
Q4 FY2018CQ1 2018Mar 31, 2018$233.55M+2.4%
Q3 FY2018CQ4 2017Dec 30, 2017$234.04M+2.7%
Q2 FY2018CQ3 2017Sep 30, 2017$225.38M+2.3%
Q1 FY2018CQ2 2017Jul 1, 2017$210.95M–
Q4 FY2017CQ1 2017Apr 1, 2017$228.07M–
Q3 FY2017CQ4 2016Dec 31, 2016$227.84M–
Q2 FY2017CQ3 2016Oct 1, 2016$220.25M–

More Haemonetics figures

See a number that looks wrong?